EP1043991A4
(en )
2005-02-02
Treatment for alzheimer's disease
EP1007048A4
(en )
2004-09-22
Identification of agents for use in the treatment of alzheimer's disease
HUP0103654A2
(en )
2002-02-28
Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
EP0735870A4
(en )
1998-08-19
Use of pla 2? inhibitors as treatment for alzheimer's disease
HUP0003852A3
(en )
2003-04-28
Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
AP2001002102A0
(en )
2001-03-31
Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
HUP0002030A3
(en )
2002-01-28
Use of glur5 receptorantagonists for the treatment of pain
IL127146A0
(en )
1999-09-22
Transdermal propentofylline compositions for the treatment of alzheimer's disease
ZA989365B
(en )
1999-04-15
Preparation for treating alzheimer's disease
IL119417A0
(en )
1997-01-10
Drug for Parkinson's disease
IL129144A0
(en )
2000-02-17
Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
IL121730A0
(en )
1998-02-22
Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
HUP0004331A3
(en )
2001-09-28
Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it
IL117695A0
(en )
1996-07-23
Pharmaceutical agents for the treatment of alzheimer's disease
GB0011410D0
(en )
2000-06-28
Therapeutic combination for treating Alzheimer's disease
AU1405899A
(en )
1999-06-07
Treatment for alzheimer's disease
GB0011408D0
(en )
2000-06-28
Therapeutic combination for treating Alzheimer's Disease
EP1181550A4
(en )
2005-03-02
Methods for the identification of compounds for the treatment of alzheimer's disease
EP0981357A4
(en )
2001-09-12
Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
EP0755262A4
(en )
1997-05-07
Composition for the treatment of lung disease
HUP0103149A3
(en )
2003-03-28
Pharmaceutical composition for treatment of alzheimer's disease
SI1007040T1
(en )
2002-10-31
Use of phanquinone for the treatment of alzheimer's disease
HUP0000569A3
(en )
2000-11-28
Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
EP0979234A4
(en )
2002-10-30
Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
GB9709416D0
(en )
1997-07-02
Methods for treatment of alzheimer's disease using azaspiranes